Nanalysis Scientific Corp.
NSCIF
$0.09
$0.00-3.71%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -76.17% | 51.99% | 28.99% | -68.41% | 82.89% |
| Total Depreciation and Amortization | -6.28% | -3.80% | -16.48% | -59.37% | 156.75% |
| Total Amortization of Deferred Charges | 122.98% | -53.15% | -15.14% | -- | -- |
| Total Other Non-Cash Items | -38.89% | 366.33% | -53.69% | -26.79% | -93.42% |
| Change in Net Operating Assets | -112.72% | 1,396.93% | 114.79% | -136.42% | 430.14% |
| Cash from Operations | -104.96% | 947.48% | 80.21% | -160.71% | 144.91% |
| Capital Expenditure | 64.67% | -188.51% | 58.51% | -67.29% | -- |
| Sale of Property, Plant, and Equipment | -13.46% | 2,871.43% | -98.51% | 571.43% | -90.93% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 57.41% | -24.63% | 9.01% | 32.14% | -49.54% |
| Cash from Investing | 61.66% | -33.57% | 4.95% | 33.34% | -134.26% |
| Total Debt Issued | -- | -200.87% | -41.72% | -- | -- |
| Total Debt Repaid | -696.77% | -1,047.22% | 128.57% | 95.05% | -246.40% |
| Issuance of Common Stock | -63.03% | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 31.30% | -7.89% | 13.31% | -16.37% | -1.80% |
| Cash from Financing | -469.25% | -22.00% | -53.69% | 159.08% | -925.94% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -188.53% | 4,015.24% | 118.25% | 43.70% | -156.59% |